Table 2.
Variable | β coefficient | RR | 95% CI | p |
---|---|---|---|---|
Age | 0.018 | 1.108 | 1.002–1.034 | 0.029 |
Sex (women) | 0.452 | 1.572 | 1.085–2.277 | 0.017 |
Height (cm) | 0.016 | 1.016 | 0.999–1.034 | 0.067 |
Alcohol-related liver disease | 0.227 | 1.254 | 0.953–1.651 | 0.106 |
Cryptogenic cirrhosis | 0.512 | 1.669 | 1.030–2.703 | 0.037 |
HCC | 0.286 | 1.331 | 0.981–1.807 | 0.067 |
Diuretics use | −0.142 | 0.868 | 0.661–1.139 | 0.307 |
Ascites (moderate-severe) | 0.354 | 1.425 | 1.062–1.911 | 0.018 |
Serum urea (mg/dL) | 0.013 | 1.013 | 1.009–1.017 | <0.001 |
Serum creatinine (mg/dL) | −0.207 | 0.813 | 0.621–1.063 | 0.131 |
Serum sodium (mmol/L) | −0.030 | 0.970 | 0.949–0.992 | 0.007 |
International normalized ratio | 0.335 | 1.398 | 1.130–1.730 | 0.002 |
Serum albumin (g/dL) | −0.109 | 0.897 | 0.740–1.087 | 0.268 |
Serum bilirubin (mg/dL) | 0.072 | 1.075 | 1.060–1.090 | <0.001 |
95% CI, 95% confidence interval; HCC, hepatocellular carcinoma.